Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Ibrance (palbociclib) Covered by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide

Quick Answer: To get Ibrance (palbociclib) covered by Aetna CVS Health in California, you need prior authorization showing HR-positive, HER2-negative advanced breast cancer diagnosis with proper documentation. Submit through CVS Specialty Pharmacy (1-866-814-5506) with pathology reports and ICD-10 codes C50.- and Z17.411. If denied, file internal appeal within

How to Get Firazyr (Icatibant) Covered by Aetna CVS Health in North Carolina: Appeals, Forms & Cost-Saving Tips

Answer Box: Getting Firazyr Covered by Aetna CVS Health in North Carolina Firazyr (icatibant) requires prior authorization from Aetna CVS Health and is excluded from many standard formularies. To get coverage in North Carolina: (1) Have your HAE specialist submit a prior authorization with confirmed HAE diagnosis and lab results,

How to Get Evrysdi (Risdiplam) Covered by Aetna in Ohio: Appeal Guide with Forms and Timelines

Answer Box: Getting Evrysdi Covered by Aetna in Ohio Fastest path to approval: Submit genetic testing documentation confirming biallelic SMN1 mutations, clinical SMA diagnosis, baseline motor assessments, and prior therapy history to Aetna's prior authorization process. If denied, file an internal appeal within 180 days, then request external

How to Get Amondys 45 (Casimersen) Covered by Aetna CVS Health in Texas: Complete Appeal Guide with Templates

Answer Box: Getting Amondys 45 Covered by Aetna CVS Health in Texas Aetna CVS Health requires prior authorization for Amondys 45 (casimersen) with strict genetic and clinical documentation. The fastest path to approval: 1. Gather genetic testing confirming DMD with exon 45 amenable mutation 2. Submit Aetna's precertification

Getting Oxbryta (Voxelotor) Covered by Aetna CVS Health in Virginia: 2024 Updates, Appeals, and Alternatives

Quick Answer: Oxbryta Coverage Status in Virginia Important Update: Oxbryta (voxelotor) is no longer FDA-approved in the United States as of 2024. Pfizer withdrew the drug following a confirmatory evidence review. If you're in Virginia with Aetna CVS Health coverage and need sickle cell disease treatment, focus on

How to Get Evrysdi (risdiplam) Covered by Aetna (CVS Health) in Pennsylvania: Forms, Appeals, and Contact Guide

Quick Answer: Evrysdi (risdiplam) requires prior authorization from Aetna (CVS Health) in Pennsylvania. Submit PA requests via the Availity provider portal with genetic confirmation, neurologist documentation, and motor function assessments. If denied, you have 180 days to appeal internally, then 4 months for Pennsylvania's external review program. Start

How to Get Elelyso (taliglucerase alfa) Covered by Aetna in Pennsylvania: Complete Approval Guide with Forms and Appeal Scripts

Answer Box: Getting Elelyso Covered by Aetna in Pennsylvania Elelyso (taliglucerase alfa) requires prior authorization from Aetna CVS Health in Pennsylvania. The fastest path to approval: 1) Confirm Type 1 Gaucher disease diagnosis with enzyme assay and genetic testing, 2) Submit PA request via Aetna provider portal with specialist documentation,

Renewing Eylea/Lucentis Approval with Aetna CVS Health in North Carolina: 2024 Timeline and Requirements

Answer Box: Quick Start for North Carolina Residents If your Eylea or Lucentis authorization is expiring with Aetna CVS Health: Start renewal 30-45 days early. You'll need updated OCT imaging, current visual acuity measurements, and documentation of continued medical necessity. Submit through your eye doctor's office

How to Get Amvuttra (vutrisiran) Approved by Aetna CVS Health in California: Formulary Alternatives, PA Requirements & Appeal Scripts

Answer Box: Getting Amvuttra Covered by Aetna CVS Health in California Aetna CVS Health requires prior authorization for Amvuttra (vutrisiran) with documented genetic testing, specialist evaluation, and evidence of failure/intolerance to preferred alternatives like tafamidis or patisiran. In California, standard PA decisions take 72 hours; urgent requests get 24-hour

How Long Does It Take to Get Ilaris (Canakinumab) Approved by Aetna CVS Health in Texas? Complete Timeline Guide

Answer Box: Getting Ilaris (Canakinumab) Covered by Aetna CVS Health in Texas Standard approval timeline: 30-45 days for prior authorization, with over 95% of eligible requests processed within 24 hours. Expedited reviews for urgent cases must be completed within 72 hours under Texas law. Fastest path to approval: 1. Prescriber